Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

Spanish Medical Residents Prioritize Work-Life Balance

Many residents say fewer on-call shifts, predictable hours and less urgent care drive specialty choice, pushing interest toward endocrinology, clinical pharmacology and occupational medicine.

Low-Dose Oral Minoxidil: Hair Growth May Peak After 6 Months

Low dose oral minoxidil yields measurable increases in frontal hair density by 3-6 months, with no further significant gains up to 36 months, a retrospective review finds.

Can Healthy Lifestyle Improve Quality of Life in Psoriasis?

High levels of physical activity, adequate sleep, and a healthy BMI are linked to lower odds of quality-of-life impairments in patients with psoriasis.

Infrequent Primary Care Consulters Face Higher Cancer Risk

Patients who visit the doctor less often before their urgent suspected cancer referrals are more likely to receive a diagnosis of cancer than those who consult more frequently.

Cosmo Pharma's Male Hair Loss Treatment Shows Sustained Hair Growth in Year‑long Study

Cosmo Pharmaceuticals said on Wednesday its experimental hair loss treatment showed sustained hair growth ⁠and long-term safety in men with common pattern baldness after a...

IDEAYA and Servier's Eye Cancer Drug Meets Trial Goal, Paving Way for FDA Application

IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of ⁠eye cancer met the main goal of a mid-to-late-stage trial, sending...

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Latest News

Many residents say fewer on-call shifts, predictable hours and less urgent care drive specialty choice, pushing interest toward endocrinology, clinical pharmacology and occupational medicine.

Low dose oral minoxidil yields measurable increases in frontal hair density by 3-6 months, with no further significant gains up to 36 months, a retrospective review finds.

High levels of physical activity, adequate sleep, and a healthy BMI are linked to lower odds of quality-of-life impairments in patients with psoriasis.

Patients who visit the doctor less often before their urgent suspected cancer referrals are more likely to receive a diagnosis of cancer than those who consult more frequently.

Cosmo Pharmaceuticals said on Wednesday its experimental hair loss treatment showed sustained hair growth ⁠and long-term safety in men with common pattern baldness after a...

IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of ⁠eye cancer met the main goal of a mid-to-late-stage trial, sending...

News All Time

Doxycycline for Acne: Impact on STIs

The lower risk for composite bacterial STI in patients taking doxycycline for acne is driven primarily by reduced risk for chlamydia, according to an analysis of TriNetX data.

India's 'Mounjaro Brides': Weight-loss Injections Become Part Of Pre-wedding Preparation

Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India.

Strength Training Potentially Beneficial in Patients With HS

Development of validated interventions and guidance for physical therapists and dermatologists — and HS patients themselves — is a goal.

Indoor Tanning Linked to Melanoma Diagnosis at Younger Age

Exposure to indoor tanning, especially before age 25, is associated with substantially earlier melanoma diagnosis compared with no exposure.

Topical Probiotics Boost Diabetic Foot Ulcer Healing

Topical probiotics significantly improve healing rates and reduce time to heal in diabetic foot ulcers, compared with placebo, in a study.

Weight-Loss Drug-Biologic Combo Boosts Relief in PsA

ACR50 scores improve when tirzepatide is added to ixekizumab in higher-BMI group, in two trials.

CLL Tied to Increased Skin Cancer Risk Over 10 Years

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and death.

TYK2 inhibitor Promising for Psoriasis in Phase 3 Studies

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety concerns emerging.

EU Backs Targeted BRAF Combo in Melanoma, Thyroid Cancer

European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and extended its use to adolescents with advanced or resected melanoma.

Incyte's Skin Disease Drug Shows Long-term Symptom Relief in Late-stage Trials

Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in ⁠two late-stage trials.

Superficial Radiation Tx Costs Exceed Mohs Surgery for NMSC

Image-guided superficial radiation therapy remains a higher-cost treatment than Mohs surgery for nonmelanoma skin cancer, a retrospective study shows.

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

Research Uncovers Mental Health Toll of Alopecia on Women

Black women are at greater risk for depression and anxiety, and scarring forms are linked to more disorders.

ICI-Related Toxicity Diagnoses Differ for Dark vs Light Skin

A review of published studies suggests that skin toxicities related to checkpoint inhibitors may be managed differently in patients with skin of color vs lighter skin tones.

Recommended News For You

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

Does pollution cause cancer?

Drug-chemo combo increases cancer treatment efficacy

New analysis helps discern benign from malignant thyroid growths

Recommended Articles For You

Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results 

Understanding the Rare Disease: Werner Syndrome Explained  

Unlocking the Power of Cryoprecipitate: A Comprehensive Guide 

Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

2.

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

3.

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

4.

Lymph node transfer reduces arm swelling after breast cancer surgery, study shows

5.

Gene therapy for glioblastoma is effectively created by researchers.

1.

Uncovering the Secrets of CA19-9: A Blood Test for Cancer Diagnosis

2.

Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia

3.

Navigating the Complexities of Esophageal Cancer Staging

4.

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion

5.

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

3.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

4.

Navigating the Complexities of Ph Negative ALL - Part XI

5.

Navigating the Complexities of Ph Negative ALL - Part XV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot